QUALITY INTELLIGENCE
Proactive Quality Orchestration: Agentic, Evidence-Grounded Release Decisioning
An advanced Pharma 4.0 agentic model enabling continuous monitoring, automated compliance,
and instant signal detection to deliver defensible, evidence-grounded release decisions.
Why Legacy Quality Intelligence Falls Short
The Cost of Static Quality System in an Always-On Industry
Pharma manufacturing is scaling across more sites, more markets, and more regulatory jurisdictions every year, and quality now has to move at the same pace. Annual product quality reviews were built for a slower, single-site era, designed to confirm a problem after the fact, not catch the signal the moment it appears.
Across multi-site manufacturing networks, closing a major deviation can stretch to 6–12 months industry-wide, and that gap only widens as production footprints grow, leaving less and less room for a purely retrospective, once-a-cycle review
Slow, Sequential Investigation
45–75 days
per major deviation, start to finish
Expertise Isn’t Scaled
8–10
specialists tied up per deviation
Stale Signals, Surfaced Late
2–4x
QA review-rework loops before release
HOW SAAMA HELPS
From Reactive Quality Control to Continuous Release Reasoning
Saama provides an Agent OS-orchestrated Quality Intelligence solution for pharma manufacturing.
By connecting historical precedent, real-time monitoring, and full batch-to-market traceability into one system, we transform fragmented quality data into evidence-grounded release decisions that move as fast as production does.
Three Pillars Behind Every Decision
OUR AGENTIC APPROACH
From retrieval-grounded investigation to cross-system impact scoping, it is a seamless agentic journey.
Drafts investigation narratives cited to source records, grounded in evidence at every step.
Systematically scans closed deviations and CAPAs for recurring themes and precursor signals.
Traverses batch genealogy across Vault, MES, and ERP to find every impacted batch or market.
A Complete, End-to-End Quality Intelligence Suite
Six agentic use cases, governed by one shared context framework.
Retrieval-grounded root-cause drafting and CAPA
recommendation from a manufacturer’s own investigation history
Confidence-scored regulatory reportability determination with citation to source criteria.
Cross-framework compliance gap analysis and predictive
inspection-risk scoring
Cross-system impact traversal for proposed process or
specification changes
Predictive release-risk scoring to prioritize quality review
attention.
Correlates training-as-CAPA against actual recurrence-rate
outcomes.
How Saama Powers Your Success
The Case for Running Quality Decisions Our Agentic Way
Trusted by leading global pharmaceutical manufacturers to streamline compliance and release
calls. Where the approach earns its keep, review over review, release over release.
Cuts the major-deviation timeline against today’s 45–75 day baseline.
Fewer passes before signature tightens each record’s path to approval.
Pre-screens every eBR entry, so reviewers focus only on the exceptions that actually need attention.
Time reclaimed from rework flows straight into investigation quality.
What Sets This Apart — Engineered to Outperform the Status Quo
See how Saama Agentic Quality Intelligence redefines the standards of traditional QMS tools.
Preemptive Risk Sensing: Systemic patterns surface well before annual review, catching what would otherwise wait until it’s too late.
Reduced Recall Exposure: Faster cross-system scoping limits the fallout to only what’s actually affected, keeping corrective action targeted.
Deterministic by Design: Every correction is rule-governed and regulatory-grade, grounded in predictable, repeatable logic.
Full Genealogy Visibility: Every batch and market link stays traceable end to end, so nothing slips through and product reaches patients sooner.
A Leaner Path to Quality: Smarter investigation and less rework compound into a measurably lower-cost operation over time.
Zero Infrastructure Disruption: Starts on standard eBR and MES exports, so your existing QMS and ERP systems remain fully intact.
Ready to turn brand spend into a measurable prescribing lift?
The next era of marketing mix isn’t built on annual models or fixed scenario lists. It belongs to leaders who
continuously model spend, simulate budget scenarios, and act on decision-ready evidence in real time, delivered by
Forward Deployed Builder (FDB) pods embedded directly in your team.
